The role of tumor infiltrating lymphocytes (TILs) and their association with PD-L1 expression and pCR after NAC have been the subject of several studies and are still being debated in clinical consensus treatment recommendations [1,14,15]. The gene discussed is CD274; the disease is neoplasm.